Skip to main content

Navigation group

Type at least 3 characters
1,081 articles

Articles

Original Research

Published on 17 Feb 2023

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab

in Multiple Sclerosis and Neuroimmunology

  • Jeffrey L. Bennett
  • Kazuo Fujihara
  • Ho Jin Kim
  • Romain Marignier
  • Kevin C. O'Connor
  • Robert C. Sergott
  • Anthony Traboulsee
  • Heinz Wiendl
  • Jens Wuerfel
  • Scott S. Zamvil
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab
Frontiers in Neurology
doi 10.3389/fneur.2023.1114667
  • 5,359 views
  • 1 citation